Valuation: USANA Health Sciences, Inc.

Market Cap 261M 228M 215M 195M 366M 25.04B 367M 2.57B 992M 12.74B 981M 960M 41B P/E 2026 *
-23.2x
P/E 2027 * 11x
Enterprise Value 261M 228M 215M 195M 366M 25.04B 367M 2.57B 992M 12.74B 981M 960M 41B EV / Sales 2026 *
0.29x
EV / Sales 2027 * 0.28x
Free-Float
59.12%
Yield 2026 *
-
Yield 2027 * -
1 day-1.39%
1 week-5.86%
Current month-0.84%
1 month+7.28%
3 months-25.11%
6 months-16.38%
Current year-27.97%
1 week 14.02
Extreme 14.02
15.37
1 month 13.44
Extreme 13.44
15.75
Current year 12.57
Extreme 12.57
23.59
1 year 12.57
Extreme 12.57
30.1
3 years 12.57
Extreme 12.57
60.9
5 years 12.57
Extreme 12.57
103.95
10 years 12.57
Extreme 12.57
137.95
Manager TitleAgeSince
Chief Executive Officer 63 2026-01-07
Director of Finance/CFO 56 2017-04-30
Chief Tech/Sci/R&D Officer 45 2024-06-30
Director TitleAgeSince
Chairman 85 1992-08-31
Director/Board Member 85 2008-08-31
Chairman 63 2020-04-30
Date Insider Type Main position Quantity % Market Cap. Importance
7/25/26 Exercice

CHIEF INFORMATION OFFICER

1,372 0.0074% -
7/25/26 Exercice

Chief Technology Officer

2,850 0.0154%
7/23/26 Exercice

Director

3,672 0.0199%
Change 5-day change 1-year change 3-year change Capi.($)
-1.39%-5.86%-52.45%-76.22% 261M
-0.34%-0.72%+8.45%+61.37% 12.05B
+1.41%+3.49%-13.91%+225.84% 9.12B
-0.11%-0.65%-23.47%-52.18% 2.31B
-0.92%+1.19%-15.37%-11.23% 1.45B
0.00%-0.18%+20.10%+77.15% 1.35B
+1.71%-1.08%+30.23%-17.94% 1.25B
+2.02%+8.72%-41.50% - 1.09B
-1.43%-1.75%-75.06%-77.91% 1.04B
+0.80%+2.95%-61.57%-71.06% 896M
Average +0.17%-0.48%-22.46%+6.43% 3.08B
Weighted average by Cap. +0.34%-0.66%-7.44%+86.76%

Financials

2026 *2027 *
Net sales 910M 792M 748M 679M 1.27B 87.19B 1.28B 8.94B 3.45B 44.36B 3.42B 3.34B 143B 950M 827M 781M 709M 1.33B 91.05B 1.33B 9.33B 3.61B 46.33B 3.57B 3.49B 149B
Net income -11.22M -9.78M -9.23M -8.38M -15.71M -1.08B -15.76M -110M -42.63M -547M -42.16M -41.23M -1.76B 23.8M 20.73M 19.58M 17.78M 33.31M 2.28B 33.42M 234M 90.39M 1.16B 89.41M 87.42M 3.74B
Net Debt - -
Logo USANA Health Sciences, Inc.
USANA Health Sciences, Inc. and subsidiaries is a global nutrition, personal health and wellness company that develops and manufactures nutritional supplements, functional foods and personal care products. Its segments include Core nutritional and Hiya direct-to-consumer. The Core nutritional segment develops and manufactures science-based nutritional, personal care and skincare products with a primary focus on promoting long-term health and wellness in various geographic markets worldwide that are distributed through the core nutritional channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the United States that are distributed through the direct-to-consumer channel. Its product line includes USANA Nutritionals Optimizers, Essentials/CellSentials, Foods, Personal care and Skincare, and All other. USANA Nutritionals Optimizers products include Proflavanol, CoQuinone 30, and BiOmega-3.
Employees
1,570
Date Price Change Volume
26-09-18 US$14.14 -1.39% 337,828
26-09-17 US$14.34 -2.52% 164,378
26-09-16 US$14.71 -1.28% 231,249
26-09-15 US$14.90 -2.42% 196,432
26-09-14 US$15.27 +1.66% 169,359
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BBB

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. USNA Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!